Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

L. Robert Rosiello


  • Evp, Corp Dev & Strategy at Valeant Pharmaceuticals International Inc. (VRX), 2016-12-07
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
VRX $257.25 704 Officer 441,675 2015-07-31 Filing
VRX $253.99 7,171 Officer 440,971 2015-07-30 Filing
VRX $232.51 12,900 Officer 12,900 2015-06-12 Filing